MedPath

Poitiers University Hospital

Poitiers University Hospital logo
🇫🇷France
Ownership
Private
Established
1961-01-01
Employees
5K
Market Cap
-
Website
https://www.chu-poitiers.fr

A Pharmacokinetic-pharmacodynamic Dose Comparison Study of 8 mg/kg of Inhaled or Parenteral Gentamicin in 12 Mechanically Ventilated Critically Ill Patients Treated for Ventilator-associated Pneumonia

Phase 1
Completed
Conditions
Ventilator-associated Pneumonia
Interventions
First Posted Date
2015-08-04
Last Posted Date
2017-03-24
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
12
Registration Number
NCT02515448
Locations
🇫🇷

BOISSON Matthieu, Poitiers, France

🇫🇷

Dequin P-F, Tours, France

Evaluation of Transcutaneous Trigeminal Nerve Stimulation for Prevention of Cerebral Vasospasm After Subarachnoid Haemorrhage

Not Applicable
Completed
Conditions
Subarachnoid Haemorrhage (SAH)
Interventions
Device: Transcutaneous Electrical Nerve Stimulation (TENS)
First Posted Date
2015-06-26
Last Posted Date
2019-11-08
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
60
Registration Number
NCT02482883
Locations
🇫🇷

BATAILLE, Poitiers, France

Impulsivity and Parkinson's Disease : a Neuropsychology With Magnetic Resonance Imaging Study

Not Applicable
Completed
Conditions
Parkinson's Disease
Interventions
Other: magnetic resonance imaging
First Posted Date
2015-06-04
Last Posted Date
2021-10-05
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
90
Registration Number
NCT02463617
Locations
🇫🇷

Pascal DERKINDEREN, Nantes, France

🇫🇷

Marc VERIN, Rennes, France

🇫🇷

Chu de Poitiers, Poitiers, France

Trial of Multidisciplinary Team Stress and Performance in Immersive Simulation for Management of Infant in Shock

Not Applicable
Completed
Conditions
Stress
Interventions
Other: MDT simulation sessions of management of life-threatening events over 1 year
First Posted Date
2015-04-23
Last Posted Date
2016-10-13
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
48
Registration Number
NCT02424890
Locations
🇫🇷

GHAZALI, Poitiers, France

Trial to Evaluate the Efficacy of Simvastatin for Smoking Cessation

Phase 2
Completed
Conditions
Smoking Cessation
Interventions
Drug: Placebo
First Posted Date
2015-03-26
Last Posted Date
2020-04-13
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
124
Registration Number
NCT02399709
Locations
🇫🇷

Poitiers University Hospital, Poitiers, France

Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function

Phase 3
Completed
Conditions
Chronic Kidney Disease
Interventions
First Posted Date
2015-01-08
Last Posted Date
2021-01-29
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
329
Registration Number
NCT02334488
Locations
🇫🇷

Angers University Hospital, Angers, France

🇫🇷

Poitiers University Hospital, Poitiers, France

🇫🇷

Reims University Hospital, Reims, France

and more 11 locations

Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3)

Phase 4
Completed
Conditions
Type 3 Choroidal Neovascularization
Interventions
First Posted Date
2014-12-19
Last Posted Date
2019-03-08
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
26
Registration Number
NCT02320474
Locations
🇫🇷

Poitiers University Hospital, Poitiers, France

🇫🇷

Polyclinic of POITIERS, Poitiers, France

Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).

Phase 2
Completed
Conditions
Allergic Bronchopulmonary Aspergillosis
Interventions
Drug: placebo
Drug: Liposomal amphotericin B (Ambisome®)
First Posted Date
2014-10-24
Last Posted Date
2020-06-09
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
174
Registration Number
NCT02273661
Locations
🇫🇷

Chu de Poitiers, Poitiers, France

PROPHY-VAP: Prevention of Early Ventilation Acquired Pneumonia (VAP) in Brain Injured Patients by a Single Dose of Ceftriaxone

Phase 3
Completed
Conditions
Early Ventilation Acquired Pneumonia in Brain Injured Patients
Interventions
Drug: Anti-Infective Agents
Drug: Placebo
First Posted Date
2014-10-15
Last Posted Date
2021-02-03
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
354
Registration Number
NCT02265406
Locations
🇫🇷

CHU, Bordeaux, France

🇫🇷

University Hospital of Poitiers, Poitiers, France

🇫🇷

University Hospital of Nantes, Nantes, France

and more 5 locations

Relationships Between Macular Pigment Optical Density and Lacquer Cracks in High Myopic Patients.

Not Applicable
Completed
Conditions
High Myopia
Interventions
Device: MPS II
First Posted Date
2014-07-31
Last Posted Date
2018-04-05
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
39
Registration Number
NCT02205632
Locations
🇫🇷

ophthalmology department, Poitiers University Hospital, Poitiers, Vienne, France

© Copyright 2025. All Rights Reserved by MedPath